Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 108 entries
Sorted by: Best Match Show Resources per page
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics.

Frontiers in immunology

Sand KM, Bern M, Nilsen J, Noordzij HT, Sandlie I, Andersen JT.
PMID: 25674083
Front Immunol. 2015 Jan 26;5:682. doi: 10.3389/fimmu.2014.00682. eCollection 2014.

The neonatal Fc receptor (FcRn) was first found to be responsible for transporting antibodies of the immunoglobulin G (IgG) class from the mother to the fetus or neonate as well as for protecting IgG from intracellular catabolism. However, it...

Cite
Sand KM, Bern M, Nilsen J, et al. Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Front Immunol. 2015;5:682doi: 10.3389/fimmu.2014.00682.
Sand, K. M., Bern, M., Nilsen, J., Noordzij, H. T., Sandlie, I., & Andersen, J. T. (2014). Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Frontiers in immunology, 5682. https://doi.org/10.3389/fimmu.2014.00682
Sand, Kine Marita Knudsen, et al. "Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics." Frontiers in immunology vol. 5 (2014): 682. doi: https://doi.org/10.3389/fimmu.2014.00682
Sand KM, Bern M, Nilsen J, Noordzij HT, Sandlie I, Andersen JT. Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Front Immunol. 2015 Jan 26;5:682. doi: 10.3389/fimmu.2014.00682. eCollection 2014. PMID: 25674083; PMCID: PMC4306297.
Copy Download .nbib Format: NLM
Renal replacement therapy in Ukraine: epidemiology and international comparisons.

Clinical kidney journal

Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager KJ.
PMID: 25852905
Clin Kidney J. 2014 Jun;7(3):330-5. doi: 10.1093/ckj/sfu037. Epub 2014 Apr 24.

BACKGROUND: Little is known about the status of renal replacement therapy (RRT) in the post-Soviet countries. We therefore investigated the epidemiology and treatment outcomes of RRT in Ukrainian patients and put the results into an international perspective.METHODS: Data from...

Cite
Kolesnyk I, Noordzij M, Kolesnyk M, et al. Renal replacement therapy in Ukraine: epidemiology and international comparisons. Clin Kidney J. 2014;7(3):330-5doi: 10.1093/ckj/sfu037.
Kolesnyk, I., Noordzij, M., Kolesnyk, M., Kulyzky, M., & Jager, K. J. (2014). Renal replacement therapy in Ukraine: epidemiology and international comparisons. Clinical kidney journal, 7(3), 330-5. https://doi.org/10.1093/ckj/sfu037
Kolesnyk, Inna, et al. "Renal replacement therapy in Ukraine: epidemiology and international comparisons." Clinical kidney journal vol. 7,3 (2014): 330-5. doi: https://doi.org/10.1093/ckj/sfu037
Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager KJ. Renal replacement therapy in Ukraine: epidemiology and international comparisons. Clin Kidney J. 2014 Jun;7(3):330-5. doi: 10.1093/ckj/sfu037. Epub 2014 Apr 24. PMID: 25852905; PMCID: PMC4377756.
Copy Download .nbib Format: NLM
Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report.

Clinical kidney journal

Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov BT, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, García Bazaga Mde L, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Lasalle M, Leivestad T, Lopot F, van de Luijtgaarden MW, Macário F, Magaz Á, Martín Escobar E, de Meester J, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera C, Pippias M, Prütz KG, Ratkovic M, Resić H, Rodríguez Hernández A, Rutkowski B, Spustová V, Stel VS, Stojceva-Taneva O, Süleymanlar G, Wanner C, Jager KJ.
PMID: 25852881
Clin Kidney J. 2014 Apr;7(2):227-38. doi: 10.1093/ckj/sfu007. Epub 2014 Mar 02.

BACKGROUND: This article provides a summary of the 2011 ERA-EDTA Registry Annual Report (available at www.era-edta-reg.org).METHODS: Data on renal replacement therapy (RRT) for end-stage renal disease (ESRD) from national and regional renal registries in 30 countries in Europe and...

Cite
Noordzij M, Kramer A, Abad Diez JM, et al. Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report. Clin Kidney J. 2014;7(2):227-38doi: 10.1093/ckj/sfu007.
Noordzij, M., Kramer, A., Abad Diez, J. M., Alonso de la Torre, R., Arcos Fuster, E., Bikbov, B. T., Bonthuis, M., Bouzas Caamaño, E., Čala, S., Caskey, F. J., Castro de la Nuez, P., Cernevskis, H., Collart, F., Díaz Tejeiro, R., Djukanovic, L., Ferrer-Alamar, M., Finne, P., García Bazaga, M. d. e. . L., Garneata, L., Golan, E., Gonzalez Fernández, R., Heaf, J. G., Hoitsma, A., Ioannidis, G. A., Kolesnyk, M., Kramar, R., Lasalle, M., Leivestad, T., Lopot, F., van de Luijtgaarden, M. W., Macário, F., Magaz, �. �., Martín Escobar, E., de Meester, J., Metcalfe, W., Ots-Rosenberg, M., Palsson, R., Piñera, C., Pippias, M., Prütz, K. G., Ratkovic, M., Resić, H., Rodríguez Hernández, A., Rutkowski, B., Spustová, V., Stel, V. S., Stojceva-Taneva, O., Süleymanlar, G., Wanner, C., & Jager, K. J. (2014). Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report. Clinical kidney journal, 7(2), 227-38. https://doi.org/10.1093/ckj/sfu007
Noordzij, Marlies, et al. "Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report." Clinical kidney journal vol. 7,2 (2014): 227-38. doi: https://doi.org/10.1093/ckj/sfu007
Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov BT, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, García Bazaga Mde L, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Lasalle M, Leivestad T, Lopot F, van de Luijtgaarden MW, Macário F, Magaz Á, Martín Escobar E, de Meester J, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera C, Pippias M, Prütz KG, Ratkovic M, Resić H, Rodríguez Hernández A, Rutkowski B, Spustová V, Stel VS, Stojceva-Taneva O, Süleymanlar G, Wanner C, Jager KJ. Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report. Clin Kidney J. 2014 Apr;7(2):227-38. doi: 10.1093/ckj/sfu007. Epub 2014 Mar 02. PMID: 25852881; PMCID: PMC4377783.
Copy Download .nbib Format: NLM
A study on the synthesis and secretion of immunoglobulins by the Jarderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old.

Avian pathology : journal of the W.V.P.A

Davelaar FG, Noordzij A, Vanderdonk JA.
PMID: 18770173
Avian Pathol. 1982;11(1):63-79. doi: 10.1080/03079458208436082.

One-day-old chickens with maternally derived antibodies to infectious bronchitis virus (IBV) were vaccinated against IB by eye-drop. At 2 and 3 weeks of age the synthesis of immunoglobulins of the IgA isotype in the Harderian gland was demonstrated by...

Cite
Davelaar FG, Noordzij A, Vanderdonk JA. A study on the synthesis and secretion of immunoglobulins by the Jarderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old. Avian Pathol. 1982;11(1):63-79doi: 10.1080/03079458208436082.
Davelaar, F. G., Noordzij, A., & Vanderdonk, J. A. (1982). A study on the synthesis and secretion of immunoglobulins by the Jarderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old. Avian pathology : journal of the W.V.P.A, 11(1), 63-79. https://doi.org/10.1080/03079458208436082
Davelaar, F G, et al. "A study on the synthesis and secretion of immunoglobulins by the Jarderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old." Avian pathology : journal of the W.V.P.A vol. 11,1 (1982): 63-79. doi: https://doi.org/10.1080/03079458208436082
Davelaar FG, Noordzij A, Vanderdonk JA. A study on the synthesis and secretion of immunoglobulins by the Jarderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old. Avian Pathol. 1982;11(1):63-79. doi: 10.1080/03079458208436082. PMID: 18770173.
Copy Download .nbib Format: NLM
Bacterial endocarditis with septic pulmonary embolism due to pacemaker lead infection.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Prins WB, Yilmaz A, Noordzij PG.
PMID: 22431017
Neth Heart J. 2014 Mar;22(3):127-8. doi: 10.1007/s12471-012-0271-0.

No abstract available.

Cite
Prins WB, Yilmaz A, Noordzij PG. Bacterial endocarditis with septic pulmonary embolism due to pacemaker lead infection. Neth Heart J. 2014;22(3):127-8doi: 10.1007/s12471-012-0271-0.
Prins, W. B., Yilmaz, A., & Noordzij, P. G. (2014). Bacterial endocarditis with septic pulmonary embolism due to pacemaker lead infection. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 22(3), 127-8. https://doi.org/10.1007/s12471-012-0271-0
Prins, W B, et al. "Bacterial endocarditis with septic pulmonary embolism due to pacemaker lead infection." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 22,3 (2014): 127-8. doi: https://doi.org/10.1007/s12471-012-0271-0
Prins WB, Yilmaz A, Noordzij PG. Bacterial endocarditis with septic pulmonary embolism due to pacemaker lead infection. Neth Heart J. 2014 Mar;22(3):127-8. doi: 10.1007/s12471-012-0271-0. PMID: 22431017; PMCID: PMC3931857.
Copy Download .nbib Format: NLM
Sources of variability in human communicative skills.

Frontiers in human neuroscience

Volman I, Noordzij ML, Toni I.
PMID: 23189048
Front Hum Neurosci. 2012 Nov 22;6:310. doi: 10.3389/fnhum.2012.00310. eCollection 2012.

When established communication systems cannot be used, people rapidly create novel systems to modify the mental state of another agent according to their intentions. However, there are dramatic inter-individual differences in the implementation of this human competence for communicative...

Cite
Volman I, Noordzij ML, Toni I. Sources of variability in human communicative skills. Front Hum Neurosci. 2012;6:310doi: 10.3389/fnhum.2012.00310.
Volman, I., Noordzij, M. L., & Toni, I. (2012). Sources of variability in human communicative skills. Frontiers in human neuroscience, 6310. https://doi.org/10.3389/fnhum.2012.00310
Volman, Inge, et al. "Sources of variability in human communicative skills." Frontiers in human neuroscience vol. 6 (2012): 310. doi: https://doi.org/10.3389/fnhum.2012.00310
Volman I, Noordzij ML, Toni I. Sources of variability in human communicative skills. Front Hum Neurosci. 2012 Nov 22;6:310. doi: 10.3389/fnhum.2012.00310. eCollection 2012. PMID: 23189048; PMCID: PMC3504324.
Copy Download .nbib Format: NLM
Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association

Yozgatli K, Lefrandt JD, Noordzij MJ, Oomen PHN, Brouwer T, Jager J, Castro Cabezas M, Smit AJ.
PMID: 29687658
Diabet Med. 2018 Apr 23; doi: 10.1111/dme.13651. Epub 2018 Apr 23.

AIM: The United Kingdom Prospective Diabetes Study (UKPDS) study showed that glycaemic control (HbAMETHODS: A prospective cohort study of 563 participants, median age 64 years [interquartile range (IQR) 57-72], diabetes duration of 13 years, from five Dutch hospitals was...

Cite
Yozgatli K, Lefrandt JD, Noordzij MJ, et al. Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus. Diabet Med. 2018;doi: 10.1111/dme.13651.
Yozgatli, K., Lefrandt, J. D., Noordzij, M. J., Oomen, P. H. N., Brouwer, T., Jager, J., Castro Cabezas, M., & Smit, A. J. (2018). Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association, . https://doi.org/10.1111/dme.13651
Yozgatli, K, et al. "Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus." Diabetic medicine : a journal of the British Diabetic Association vol. (2018). doi: https://doi.org/10.1111/dme.13651
Yozgatli K, Lefrandt JD, Noordzij MJ, Oomen PHN, Brouwer T, Jager J, Castro Cabezas M, Smit AJ. Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus. Diabet Med. 2018 Apr 23; doi: 10.1111/dme.13651. Epub 2018 Apr 23. PMID: 29687658.
Copy Download .nbib Format: NLM
An update of the ERA-EDTA Registry primary renal disease coding system: what's new?.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Noordzij M, Cornet R, Simpson K, Jager KJ, Tomson CRV.
PMID: 30445472
Nephrol Dial Transplant. 2019 Jun 01;34(6):896-898. doi: 10.1093/ndt/gfy343.

No abstract available.

Cite
Noordzij M, Cornet R, Simpson K, et al. An update of the ERA-EDTA Registry primary renal disease coding system: what's new?. Nephrol Dial Transplant. 2019;34(6):896-898doi: 10.1093/ndt/gfy343.
Noordzij, M., Cornet, R., Simpson, K., Jager, K. J., & Tomson, C. R. V. (2019). An update of the ERA-EDTA Registry primary renal disease coding system: what's new?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 34(6), 896-898. https://doi.org/10.1093/ndt/gfy343
Noordzij, Marlies, et al. "An update of the ERA-EDTA Registry primary renal disease coding system: what's new?." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 34,6 (2019): 896-898. doi: https://doi.org/10.1093/ndt/gfy343
Noordzij M, Cornet R, Simpson K, Jager KJ, Tomson CRV. An update of the ERA-EDTA Registry primary renal disease coding system: what's new?. Nephrol Dial Transplant. 2019 Jun 01;34(6):896-898. doi: 10.1093/ndt/gfy343. PMID: 30445472.
Copy Download .nbib Format: NLM
Improving the Hydrolysis Rate of the Renewable Poly(hexamethylene sebacate) Through Copolymerization of a Bis(pyrrolidone)-Based Dicarboxylic Acid.

Polymers

Noordzij GJ, Roy M, Bos N, Reinartz V, Wilsens CHRM.
PMID: 31614558
Polymers (Basel). 2019 Oct 11;11(10). doi: 10.3390/polym11101654.

In this work, we report on the synthesis of a series of polyesters based on 1,6-hexanediol, sebacic acid, and

Cite
Noordzij GJ, Roy M, Bos N, et al. Improving the Hydrolysis Rate of the Renewable Poly(hexamethylene sebacate) Through Copolymerization of a Bis(pyrrolidone)-Based Dicarboxylic Acid. Polymers (Basel). 2019;11(10)doi: 10.3390/polym11101654.
Noordzij, G. J., Roy, M., Bos, N., Reinartz, V., & Wilsens, C. H. R. M. (2019). Improving the Hydrolysis Rate of the Renewable Poly(hexamethylene sebacate) Through Copolymerization of a Bis(pyrrolidone)-Based Dicarboxylic Acid. Polymers, 11(10), . https://doi.org/10.3390/polym11101654
Noordzij, Geert J, et al. "Improving the Hydrolysis Rate of the Renewable Poly(hexamethylene sebacate) Through Copolymerization of a Bis(pyrrolidone)-Based Dicarboxylic Acid." Polymers vol. 11,10 (2019). doi: https://doi.org/10.3390/polym11101654
Noordzij GJ, Roy M, Bos N, Reinartz V, Wilsens CHRM. Improving the Hydrolysis Rate of the Renewable Poly(hexamethylene sebacate) Through Copolymerization of a Bis(pyrrolidone)-Based Dicarboxylic Acid. Polymers (Basel). 2019 Oct 11;11(10). doi: 10.3390/polym11101654. PMID: 31614558; PMCID: PMC6835251.
Copy Download .nbib Format: NLM
Renal replacement therapy in Europe-a summary of the 2009 ERA-EDTA Registry Annual Report.

Clinical kidney journal

van de Luijtgaarden MWM, Noordzij M, Wanner C, Jager KJ.
PMID: 29497512
Clin Kidney J. 2012 Apr;5(2):109-119. doi: 10.1093/ndtplus/sfr182.

INTRODUCTION: This study provides a summary of the 2009 ERA-EDTA Registry Report, with a focus on the differences in the incidence and prevalence of haemodialysis (HD), peritoneal dialysis (PD) and renal transplantation between countries and over time.METHODS: For this...

Cite
van de Luijtgaarden MWM, Noordzij M, Wanner C, et al. Renal replacement therapy in Europe-a summary of the 2009 ERA-EDTA Registry Annual Report. Clin Kidney J. 2012;5(2):109-119doi: 10.1093/ndtplus/sfr182.
van de Luijtgaarden, M. W. M., Noordzij, M., Wanner, C., & Jager, K. J. (2012). Renal replacement therapy in Europe-a summary of the 2009 ERA-EDTA Registry Annual Report. Clinical kidney journal, 5(2), 109-119. https://doi.org/10.1093/ndtplus/sfr182
van de Luijtgaarden, Moniek W M, et al. "Renal replacement therapy in Europe-a summary of the 2009 ERA-EDTA Registry Annual Report." Clinical kidney journal vol. 5,2 (2012): 109-119. doi: https://doi.org/10.1093/ndtplus/sfr182
van de Luijtgaarden MWM, Noordzij M, Wanner C, Jager KJ. Renal replacement therapy in Europe-a summary of the 2009 ERA-EDTA Registry Annual Report. Clin Kidney J. 2012 Apr;5(2):109-119. doi: 10.1093/ndtplus/sfr182. PMID: 29497512; PMCID: PMC5783206.
Copy Download .nbib Format: NLM
Renewable (Bis)pyrrolidone Based Monomers as Components for Thermally Curable and Enzymatically Depolymerizable 2-Oxazoline Thermoset Resins.

ACS sustainable chemistry & engineering

Roy M, Noordzij GJ, van den Boomen Y, Rastogi S, Wilsens CHRM.
PMID: 29780674
ACS Sustain Chem Eng. 2018 Apr 02;6(4):5053-5066. doi: 10.1021/acssuschemeng.7b04716. Epub 2018 Feb 27.

In this study we describe the synthesis of bis(pyrrolidone) based dicarboxylic acids from itaconic acid and their application in 2-oxazoline resins for fully renewable thermoset materials. The monomers are obtained using a bulk aza-Michael addition of a diamine and...

Cite
Roy M, Noordzij GJ, van den Boomen Y, et al. Renewable (Bis)pyrrolidone Based Monomers as Components for Thermally Curable and Enzymatically Depolymerizable 2-Oxazoline Thermoset Resins. ACS Sustain Chem Eng. 2018;6(4):5053-5066doi: 10.1021/acssuschemeng.7b04716.
Roy, M., Noordzij, G. J., van den Boomen, Y., Rastogi, S., & Wilsens, C. H. R. M. (2018). Renewable (Bis)pyrrolidone Based Monomers as Components for Thermally Curable and Enzymatically Depolymerizable 2-Oxazoline Thermoset Resins. ACS sustainable chemistry & engineering, 6(4), 5053-5066. https://doi.org/10.1021/acssuschemeng.7b04716
Roy, Manta, et al. "Renewable (Bis)pyrrolidone Based Monomers as Components for Thermally Curable and Enzymatically Depolymerizable 2-Oxazoline Thermoset Resins." ACS sustainable chemistry & engineering vol. 6,4 (2018): 5053-5066. doi: https://doi.org/10.1021/acssuschemeng.7b04716
Roy M, Noordzij GJ, van den Boomen Y, Rastogi S, Wilsens CHRM. Renewable (Bis)pyrrolidone Based Monomers as Components for Thermally Curable and Enzymatically Depolymerizable 2-Oxazoline Thermoset Resins. ACS Sustain Chem Eng. 2018 Apr 02;6(4):5053-5066. doi: 10.1021/acssuschemeng.7b04716. Epub 2018 Feb 27. PMID: 29780674; PMCID: PMC5953565.
Copy Download .nbib Format: NLM
The Role of the Respiratory Microbiome and Viral Presence in Lower Respiratory Tract Infection Severity in the First Five Years of Life.

Microorganisms

Hoefnagels I, van de Maat J, van Kampen JJA, van Rossum A, Obihara C, Tramper-Stranders GA, Heikema AP, de Koning W, van Wermerskerken AM, Horst-Kreft D, Driessen GJA, Punt J, Smit FJ, Stubbs A, Noordzij JG, Hays JP, Oostenbrink R.
PMID: 34361882
Microorganisms. 2021 Jul 05;9(7). doi: 10.3390/microorganisms9071446.

Lower respiratory tract infections (LRTIs) in children are common and, although often mild, a major cause of mortality and hospitalization. Recently, the respiratory microbiome has been associated with both susceptibility and severity of LRTI. In this current study, we...

Cite
Hoefnagels I, van de Maat J, van Kampen JJA, et al. The Role of the Respiratory Microbiome and Viral Presence in Lower Respiratory Tract Infection Severity in the First Five Years of Life. Microorganisms. 2021;9(7)doi: 10.3390/microorganisms9071446.
Hoefnagels, I., van de Maat, J., van Kampen, J. J. A., van Rossum, A., Obihara, C., Tramper-Stranders, G. A., Heikema, A. P., de Koning, W., van Wermerskerken, A. M., Horst-Kreft, D., Driessen, G. J. A., Punt, J., Smit, F. J., Stubbs, A., Noordzij, J. G., Hays, J. P., & Oostenbrink, R. (2021). The Role of the Respiratory Microbiome and Viral Presence in Lower Respiratory Tract Infection Severity in the First Five Years of Life. Microorganisms, 9(7), . https://doi.org/10.3390/microorganisms9071446
Hoefnagels, Ivo, et al. "The Role of the Respiratory Microbiome and Viral Presence in Lower Respiratory Tract Infection Severity in the First Five Years of Life." Microorganisms vol. 9,7 (2021). doi: https://doi.org/10.3390/microorganisms9071446
Hoefnagels I, van de Maat J, van Kampen JJA, van Rossum A, Obihara C, Tramper-Stranders GA, Heikema AP, de Koning W, van Wermerskerken AM, Horst-Kreft D, Driessen GJA, Punt J, Smit FJ, Stubbs A, Noordzij JG, Hays JP, Oostenbrink R. The Role of the Respiratory Microbiome and Viral Presence in Lower Respiratory Tract Infection Severity in the First Five Years of Life. Microorganisms. 2021 Jul 05;9(7). doi: 10.3390/microorganisms9071446. PMID: 34361882; PMCID: PMC8307314.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 108 entries